No Data
No Data
Codexis to Sell Pompe, Fabry Assets to Crosswalk Therapeutics
6-K: 2024 Annual Integrated Report
20-F: Registration statement / Annual report / Transition report
6-K: Notice of Resolutions at the 148th Ordinary General Meeting of Shareholders
Takeda Announces the Publication of Its Annual Report on Form 20-F for FY2023
OSAKA, Japan, June 26, 2024 – Takeda (TSE:4502/NYSE:TAK) today announced that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2024 (the "Annual Report") with the U.S. S
Wave Jumps on Trial Data for Huntington's Disease Therapy
Greenhorn Dav : learn from mistakes n improve...U can do it
ArrayfunctionOP Greenhorn Dav: Thanks for the encouragement!
One thing I forgot to mention is how much I have always appreciated the Moomoo community. I can't remember a single time I had a negative interaction with another user. Reflecting now, that played a huge role in making me feel like I belong here and kept any big loss or dumb play make me hit the eject button.
Of all the places on the internet, who would have thought it'd be a group of stock traders where everyone gets along and respects one another? So a big thanks to anyone else out there reading this too!